# HOWL (Werewolf Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Werewolf Therapeutics, Inc. reported $42.75M in total assets and a net loss of $28.12M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/HOWL
- Markdown: https://convexityos.com/fundamentals/HOWL.md
- SEC CIK: 0001785530
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:53 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001785530&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$25.59M | Operating profit |
| Net Income | FY 2025 | -$28.12M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.58 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$60.29M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $41.87M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $44.83M | $56.43M | $41.78M | $53.76M | $35.27M | $16.64M |
| Total Operating Expenses | $60.68M | $75.48M | $60.45M | $72.46M | $50.09M | $22.40M |
| **Operating Income** | -$60.68M | -$73.59M | -$40.50M | -$56.06M | -$50.09M | -$22.40M |
| **EBITDA** | -$59.04M | -$71.78M | -$38.74M | -$54.95M | -$49.87M | -$22.25M |
| Interest Income | $3.11M | $6.67M | $7.42M | $1.91M | -- | -- |
| Interest Expense | $5.27M | $4.66M | $3.14M | $0 | -- | -- |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- |
| **Net Income** | -$60.82M | -$70.52M | -$37.37M | -$53.81M | -$49.98M | -$15.04M |
| Basic EPS | -$1.32 | -$1.63 | -$1.05 | -$1.86 | -$10.94 | -$28.08 |
| **Diluted EPS** | -$1.33 | -$1.63 | -$1.05 | -$1.86 | -$10.94 | -$28.08 |
| Basic Shares Outstanding | 46.0M | 43.3M | 35.6M | 28.9M | 18.5M | 1.0M |
| Diluted Shares Outstanding | 46.8M | 43.9M | 35.6M | 28.9M | 18.5M | 1.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.17M | $6.16M | $8.18M | $6.93M | $11.63M | $13.14M | $13.12M | $15.73M |
| Total Operating Expenses | $10.05M | $13.84M | $13.27M | $9.42M | $15.73M | $17.54M | $17.99M | $20.35M |
| **Operating Income** | -$10.05M | $7.16M | -$13.27M | -$9.42M | -$15.73M | -$17.54M | -$17.99M | -$20.35M |
| **EBITDA** | -$8.79M | $9.61M | -$12.87M | -$9.02M | -$15.32M | -$17.14M | -$17.57M | -$19.91M |
| Interest Income | $183K | $277K | $433K | $564K | $697K | $850K | $997K | $1.31M |
| Interest Expense | $0 | $475K | $1.37M | $1.37M | $1.34M | $1.30M | $1.26M | $1.27M |
| **Net Income** | -$9.88M | $3.67M | -$13.53M | -$8.38M | -$16.37M | -$17.98M | -$18.09M | -$20.40M |
| Basic EPS | -$0.20 | $0.08 | -$0.28 | -- | -$0.36 | -$0.40 | -$0.40 | -- |
| **Diluted EPS** | -$0.20 | $0.08 | -$0.28 | -- | -$0.36 | -$0.40 | -$0.40 | -- |
| Basic Shares Outstanding | 48.6M | 48.6M | 48.6M | -- | 45.8M | 45.0M | 44.8M | -- |
| Diluted Shares Outstanding | 48.6M | 48.6M | 49.4M | -- | 45.8M | 45.0M | 44.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $57.05M | $111.0M | $134.3M | $129.3M | $157.5M | $92.57M |
| **Cash & Short-Term Investments** | $57.05M | $111.0M | $134.3M | $129.3M | $157.5M | $92.57M |
| **Total Current Assets** | $58.59M | $113.1M | $138.4M | $140.2M | $161.1M | $92.91M |
| Property, Plant & Equipment, Net | $4.69M | $6.32M | $7.96M | $8.99M | $2.91M | $651K |
| Other Non-Current Assets | $5.0K | $320K | $594K | $1.38M | $649K | $0 |
| **Total Non-Current Assets** | $10.81M | $13.86M | $36.46M | $20.05M | $18.18M | $3.48M |
| **Total Assets** | $69.40M | $126.9M | $174.8M | $160.2M | $179.2M | $96.40M |
| Accounts Payable | $754K | $3.04M | $1.34M | $1.22M | $2.04M | $1.02M |
| Deferred Revenue (Current) | $0 | $0 | $907K | $6.53M | $0 | -- |
| Other Current Liabilities | -- | -- | -- | $6.53M | $0 | $0 |
| **Total Current Liabilities** | $36.15M | $15.18M | $19.38M | $23.99M | $11.87M | $5.28M |
| Long-Term Debt | $32.09M | $32.09M | $40.00M | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | $0 | $433K | $1.13M | $0 | -- |
| Other Non-Current Liabilities | -- | -- | $0 | $191K | $0 | $31K |
| **Total Non-Current Liabilities** | $8.44M | $38.36M | $44.08M | $13.92M | $14.59M | $1.90M |
| **Total Liabilities** | $44.59M | $53.54M | $63.46M | $37.91M | $26.46M | $7.18M |
| **Total Debt (incl. Leases)** | $41.52M | $43.08M | $52.60M | $14.68M | $15.66M | $2.54M |
| Common Stock | $5.0K | $5.0K | $4.0K | $3.0K | $2.0K | $2.0K |
| Retained Earnings | -$475.4M | -$414.6M | -$344.1M | -$306.7M | -$252.9M | -$51.87M |
| **Total Stockholders' Equity** | $24.80M | $73.39M | $111.4M | $122.3M | $152.8M | -$51.86M |
| Total Equity | $24.80M | $73.39M | $111.4M | $122.3M | $152.8M | -$51.86M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $41.87M | $21.99M | $46.45M | $57.05M | $65.71M | $77.60M | $92.04M | $111.0M |
| **Cash & Short-Term Investments** | $41.87M | $21.99M | $46.45M | $57.05M | $65.71M | $77.60M | $92.04M | $111.0M |
| **Total Current Assets** | $42.75M | $22.89M | $48.73M | $58.59M | $68.17M | $80.44M | $94.46M | $113.1M |
| Property, Plant & Equipment, Net | $0 | $1.26M | $4.29M | $4.69M | $5.09M | $5.49M | $5.90M | $6.32M |
| Other Non-Current Assets | $0 | $0 | $0 | $5.0K | $46K | $122K | $179K | $320K |
| **Total Non-Current Assets** | $0 | $1.26M | $9.29M | $10.81M | $11.45M | $12.13M | $12.78M | $13.86M |
| **Total Assets** | $42.75M | $24.16M | $58.02M | $69.40M | $79.63M | $92.57M | $107.2M | $126.9M |
| Accounts Payable | $2.43M | $1.94M | $3.57M | $754K | $1.08M | $2.77M | $986K | $3.04M |
| Deferred Revenue (Current) | $28.85M | -- | -- | $0 | -- | -- | -- | $0 |
| **Total Current Liabilities** | $35.99M | $7.86M | $38.52M | $36.15M | $17.60M | $15.17M | $11.67M | $15.18M |
| Long-Term Debt | -- | -- | $32.09M | $32.09M | $32.09M | $32.09M | $32.09M | $32.09M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $0 | $0 | $7.30M | $8.44M | $32.41M | $35.93M | $38.26M | $38.36M |
| **Total Liabilities** | $35.99M | $7.86M | $45.82M | $44.59M | $50.01M | $51.10M | $49.93M | $53.54M |
| **Total Debt (incl. Leases)** | -- | -- | $40.91M | $41.52M | $41.73M | $42.13M | $42.51M | $43.08M |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$495.1M | -$485.3M | -$488.9M | -$475.4M | -$467.0M | -$450.7M | -$432.7M | -$414.6M |
| **Total Stockholders' Equity** | $6.76M | $16.29M | $12.20M | $24.80M | $29.61M | $41.46M | $57.31M | $73.39M |
| Total Equity | $6.76M | $16.29M | $12.20M | $24.80M | $29.61M | $41.46M | $57.31M | $73.39M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$60.82M | -$70.52M | -$37.37M | -$53.81M | -$49.98M | -$15.04M |
| Depreciation & Amortization | $1.63M | $1.81M | $1.76M | $1.10M | $216K | $150K |
| Stock-Based Compensation | $6.25M | $8.83M | $8.01M | $7.40M | $4.09M | $632K |
| Change in Payables | -- | -- | -- | -$883K | $1.01M | $388K |
| **Operating Cash Flow** | -$60.29M | -$56.19M | -$32.61M | -$40.60M | -$42.88M | -$18.62M |
| Capital Expenditure | $0 | -$254K | -$769K | -$3.61M | -$498K | -$560K |
| **Free Cash Flow** | -$60.29M | -$56.44M | -$33.38M | -$44.21M | -$43.37M | -$19.18M |
| **Investing Cash Flow** | $0 | -$254K | -$769K | -$3.61M | -$498K | -$560K |
| Common Stock Issued | $5.94M | $23.58M | $18.33M | $15.74M | $0 | -- |
| **Financing Cash Flow** | $6.03M | $13.08M | $58.43M | $15.91M | $109.4M | $93.86M |
| **Net Change in Cash** | -$54.26M | -$43.36M | $25.05M | -$28.30M | $66.05M | $74.67M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$9.88M | $3.67M | -$13.53M | -$8.38M | -$16.37M | -$17.98M | -$18.09M | -$20.40M |
| Depreciation & Amortization | $1.26M | $2.45M | $398K | $400K | $402K | $406K | $426K | $442K |
| Stock-Based Compensation | $344K | $419K | $929K | $1.21M | $1.23M | $1.79M | $2.01M | $1.91M |
| **Operating Cash Flow** | -$8.97M | $6.63M | -$10.60M | -$11.02M | -$15.16M | -$15.16M | -$18.95M | -$14.25M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | -$123K |
| **Free Cash Flow** | -- | -- | -- | -$11.02M | -$15.16M | -$15.16M | -$18.95M | -$14.38M |
| **Investing Cash Flow** | -- | -- | -- | $0 | $0 | $0 | $0 | -$123K |
| Common Stock Issued | -- | -- | -- | $2.32M | $3.27M | $347K | $0 | $2.48M |
| **Financing Cash Flow** | -- | -- | -- | $2.37M | $3.27M | $388K | $0 | $2.55M |
| **Net Change in Cash** | $19.88M | -$25.37M | -$10.60M | -$8.66M | -$11.88M | -$14.78M | -$18.95M | -$11.83M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -245.2% | -96.1% | -33.6% | -44.0% | -32.7% | -- |
| Return on Assets (ROA) | -87.6% | -55.6% | -21.4% | -33.6% | -27.9% | -15.6% |
| Current Ratio | 1.62x | 7.45x | 7.14x | 5.84x | 13.56x | 17.58x |
| Quick Ratio | 1.58x | 7.31x | 6.93x | 5.39x | 13.27x | 17.52x |
| Debt to Equity | 1.67x | 0.59x | 0.47x | 0.12x | 0.10x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -416.0% | -212.5% | -461.1% | -245.2% | -246.0% | -176.4% | -126.4% | -96.1% |
| Return on Assets (ROA) | -65.8% | -143.3% | -97.0% | -87.6% | -91.5% | -79.0% | -67.5% | -55.6% |
| Current Ratio | 1.19x | 2.91x | 1.27x | 1.62x | 3.87x | 5.30x | 8.09x | 7.45x |
| Quick Ratio | 1.16x | 2.80x | 1.21x | 1.58x | 3.73x | 5.11x | 7.89x | 7.31x |
| Debt to Equity | -- | -- | 3.35x | 1.67x | 1.41x | 1.02x | 0.74x | 0.59x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
